The North America botulinum toxin market was valued at US$ 4,801.29 million in 2023 and is expected to reach US$ 12,072.60 million by 2031; it is estimated to register a CAGR of 12.2% from 2023 to 2031.
Expanding Therapeutic Applications Drive Growth in North America botulinum toxin market
Botulinum toxins type A and B work by blocking the release of acetylcholine at...
Sobre
Terms And Conditions
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek